Richard Woodford, Global Procurement Director at GSK
GSK Logo

Richard Woodford


Global Procurement Director
GSK

Check out the incredible speaker line-up to see who will be joining Richard.

Download The Latest Agenda

Day 2: Optimising the Efficiency and Effectiveness of Marketing Procurement

Friday, March 6th, 2015


14:30 Case Study Revolution: How to use Marketing Procurement “Value Add” proposition to drive closer interaction and collaboration with marketing to create a competitive edge

  • What is your Value Add proposition? What would you list as your top 10?
  • How do you “Sell” Procurement’s Value Add proposition into marketing?
  • How do you go about communicating these Value Add successes to your Marketing stakeholders? How are your successes judged?
  • Do you have examples of either quantitative or qualitative measurements of value success?
  • How do you develop your partner relationships with marketing?
  • How do you build mutual accountability with marketing?
  • How do you translate this value to creating a competitive edge and communicate this?

14:50 Case Study Revolution: Continued

  • How to align procurement targets with KPI’s of marketing- who are measured on delivering sales, brand performance and health
  • Where should marketing procurement sit within the organisation?
  • How to enable your marketing procurement organisation to become a natural ally of the marketing organisation and their supply partners
  • How to build mutual accountability to keep a partnership healthy
  • How you can build a stable foundation of ‘selling’ internally to gain alignment to common goals, showcase wins, and continuously improve
  • Mastering the art and science of partnering with the business to deliver value for the company and meet the collective objectives of Marketing and Procurement

Day 3: Taking your marketing procurement to the next level

Monday, April 6th, 2015


11:50 Case Study - How the GSK global supplier engagement programme changed internal and external behaviours to maximise transparency and value

• Unveiling the operations of the global supplier engagement programme-what was asked and how results were measured to create a baseline?
• Sharing the positive and negative results from the survey- monitoring 110,000 employees across 115 markets working in a heavily regulated sector
• Extended insight post GSK merger with Novartis consumer division
• How internal and external behaviours have changed to maximise transparency and value- to drive the global agenda but not at the expense of the regional and local quality or delivery